Coronavirus live updates | Laurus Labs gets DRDO licence to make anti-COVID drug 2DG
[ad_1]
The Central authorities has despatched multi-disciplinary groups to Kerala, Arunachal Pradesh, Tripura, Odisha, Chhattisgarh and Manipur, that are reporting a excessive variety of COVID-19 instances. The two-member groups despatched to States comprise a clinician and a public well being knowledgeable every.
“Teams will be supporting them in their efforts for targeted COVID response and management, and effectively tackling the pandemic,” mentioned a authorities launch.
You can observe coronavirus instances, deaths and testing charges on the nationwide and State ranges right here. An inventory of State Helpline numbers is offered as effectively.
Here are the newest updates:
Telangana
Laurus Labs gets DRDO licence to make anti-COVID drug 2DG
Drugmaker Laurus Labs has acquired licence from Defence Research and Development Organisation (DRDO) to manufacture and market 2-Deoxy-D-Glucose (2DG), an oral drug indicated as an adjunct remedy for hospitalised COVID-19 sufferers.
Announcing this, the corporate mentioned it has already utilized for emergency use authorisation for the product with the Central Drugs Standard Control Organization. The Drugs Controller General of India (DCGI) had on May 1 accorded emergency approval to be used of 2DG on COVID-19 sufferers.
Laurus Labs is amongst a clutch of corporations which were issued licence to manufacture and market 2-DG, sources mentioned. DRDO had final month invited expression of curiosity, from pharma corporations, providing switch of know-how of the method for manufacturing 2-DG.
[ad_2]
